Midnolin‐proteasome pathway for protein degradation (Englisch)
Freier Zugriff
- Neue Suche nach: Jin, Wei‐Lin
- Neue Suche nach: Jin, Wei‐Lin
In:
MedComm
;
4
, 6
;
2023
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Midnolin‐proteasome pathway for protein degradation
-
Beteiligte:Jin, Wei‐Lin ( Autor:in )
-
Erschienen in:MedComm ; 4, 6
-
Verlag:
-
Erscheinungsdatum:01.12.2023
-
Format / Umfang:3 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 4, Ausgabe 6
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
-
Non‐invasive omics analysis delineates molecular changes in water‐only fasting and its sex‐discriminating features in metabolic syndrome patientsJiang, Yanyu / Tang, Zhimei / Zhu, Xiaogang / Xiao, Biying / Tian, Hechuan / Lei, Xingxing / Peng, Huan / Qin, Jun / Zhang, Yanmei / Hoffman, Robert M. et al. | 2023
-
Single‐cell transcriptomic atlas of distinct early immune responses induced by SARS‐CoV‐2 Proto or its variants in rhesus monkeyYang, Yun / Du, Tingfu / Yu, Wenhai / Zhou, Yanan / Yang, Chengyun / Kuang, Dexuan / Wang, Junbin / Tang, Cong / Wang, Haixuan / Zhao, Yuan et al. | 2023
-
Integrated transcriptomics, proteomics, and functional analysis to characterize the tissue‐specific small extracellular vesicle network of breast cancerShen, Lesang / Huang, Huanhuan / Wei, Zichen / Chen, Wuzhen / Li, Jiaxin / Yao, Yao / Zhou, Jun / Liu, Jian / Sun, Shanshan / Xia, Wenjie et al. | 2023
-
Tumor‐derived extracellular vesicles and particles (EVPs): pivotal vectors in driving metabolic reprogrammingSu, Xinming / Zheng, Peijie / Duan, Shiwei et al. | 2023
-
Activating the STING pathway to prevent dormant metastasis in lung adenocarcinomaMa, Jin / Lian, Xiaoqi / Liu, Sijia et al. | 2023
-
The role of mitochondrial dynamics in diseaseWang, Yujuan / Dai, Xinyan / Li, Hui / Jiang, Huiling / Zhou, Junfu / Zhang, Shiying / Guo, Jiacheng / Shen, Lidu / Yang, Huantao / Lin, Jie et al. | 2023
-
A comprehensive model for tRNA methylation modification studiesWeng, Qi / Zhang, Feng / Zheng, Quan et al. | 2023
-
Low‐dose exercise protects the heart against established myocardial infarction via IGF‐1‐upregulated CTRP9 in male miceTan, Yanzhen / Feng, Pan / Feng, Lele / Shi, Lei / Song, Yujie / Yang, Jian / Duan, Weixun / Gao, Erhe / Liu, Jincheng / Yi, Dinghua et al. | 2023
-
Potential therapies targeting nuclear metabolic regulation in cancerChen, Yanjie / Xu, Jie / Liu, Xiaoyi / Guo, Linlin / Yi, Ping / Cheng, Chunming et al. | 2023
-
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapyCao, Jiangjun / Zhang, Zhe / Zhou, Li / Luo, Maochao / Li, Lei / Li, Bowen / Nice, Edouard C. / He, Weifeng / Zheng, Shaojiang / Huang, Canhua et al. | 2023
-
Nrf2/PHB2 alleviates mitochondrial damage and protects against Staphylococcus aureus‐induced acute lung injuryJin, Si‐Hao / Sun, Jiao‐Jiao / Liu, Gang / Shen, Li‐Juan / Weng, Yuan / Li, Jin‐You / Chen, Min / Wang, Ying‐Ying / Gao, Zhi‐Qi / Jiang, Feng‐Juan et al. | 2023
-
Identification of RP11‐770J1.4 as immune‐related lncRNA regulating the CTXN1–cGAS–STING axis in histologically lower‐grade gliomaZhuang, Qiyuan / Liu, Chaxian / Hu, Yihan / Liu, Ying / Lyu, Yingying / Liao, Yuheng / Chen, Liang / Yang, Hui / Mao, Ying et al. | 2023
-
Methylation of ESR1 promoter induced by SNAI2–DNMT3B complex promotes epithelial–mesenchymal transition and correlates with poor prognosis in ERα‐positive breast cancersLi, Ji‐Wei / Deng, Qiu‐Min / Zhu, Jian‐Ling / Min, Wei / Hu, Xiao‐Yi / Yu Chen, Hong‐ / Luo, Zhong / Lin, Lin‐Ling / Wei, Xiao‐Long / Zhang, Yong‐Qu et al. | 2023
-
Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologiesSong, Yujie / Tan, Yanzhen / Deng, Meng / Shan, Wenju / Zheng, Wenying / Zhang, Bing / Cui, Jun / Feng, Lele / Shi, Lei / Zhang, Miao et al. | 2023
-
Co‐targeting FAK and Gli1 inhibits the tumor‐associated macrophages‐released CCL22‐mediated esophageal squamous cell carcinoma malignancyChen, Jie / Zhu, Yanmeng / Zhao, Di / Zhang, Lingyuan / Zhang, Jing / Xiao, Yuanfan / Wu, Qingnan / Wang, Yan / Zhan, Qimin et al. | 2023
-
Systemic allergic contact dermatitis to palladium, platinum, and titanium: mechanisms, clinical manifestations, prevalence, and therapeutic approachesSadrolvaezin, Ali / Pezhman, Arezou / Zare, Iman / Nasab, Shima Zahed / Chamani, Sajad / Naghizadeh, Ali / Mostafavi, Ebrahim et al. | 2023
-
New discoveries on how DICER efficiently processes pre‐miRNAWeng, Qi / Wu, Qi / Zheng, Quan et al. | 2023
-
Ubiquitin‐specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinomaYe, Qianwei / Zhou, Wei / Xu, Shengjun / Que, Qingyang / Zhan, Qifan / Zhang, Lincheng / Zheng, Shusen / Ling, Sunbin / Xu, Xiao et al. | 2023
-
BDH1‐mediated LRRC31 regulation dependent on histone lysine β‐hydroxybutyrylation to promote lung adenocarcinoma progressionHuang, Jingjing / Liang, Lu / Jiang, Shiyao / Liu, Yueying / He, Hua / Sun, Xiaoyan / Li, Yi / Xie, Li / Tao, Yongguang / Cong, Li et al. | 2023
-
Targeted therapies in bladder cancer: signaling pathways, applications, and challengesPeng, Mei / Chu, Xuetong / Peng, Yan / Li, Duo / Zhang, Zhirong / Wang, Weifan / Zhou, Xiaochen / Xiao, Di / Yang, Xiaoping et al. | 2023
-
SARS‐CoV‐2 booster immunization: stimulating de novo B‐cell response and antibody generationHong, Qiaonan / Bai, Ziyi / Tian, Dong et al. | 2023
-
Genome‐wide meta‐analysis and fine‐mapping prioritize potential causal variants and genes related to leprosyWang, Zhenzhen / Liu, Tingting / Li, Wenchao / Yu, Gongqi / Mi, Zihao / Wang, Chuan / Liao, Xiaojie / Huai, Pengcheng / Chu, Tongsheng / Liu, Dianchang et al. | 2023
-
Cyclical endometrial repair and regeneration: Molecular mechanisms, diseases, and therapeutic interventionsHu, Xulin / Wu, Haoming / Yong, Xin / Wang, Yao / Yang, Shuhao / Fan, Diyi / Xiao, Yibo / Che, Lanyu / Shi, Kun / Li, Kainan et al. | 2023
-
Transcription factor 19‐mediated epigenetic regulation of FOXM1/AURKB axis contributes to proliferation in clear cell renal carcinoma cellsLuo, Yakun / Shi, Qing / Wang, Lu / Li, Shuijie / Xu, Wanhai et al. | 2023
-
Preoperative treatment of locally advanced rectal cancer: less is moreWeng, Shanshan / Zhong, Chenhan / Sun, Weijing / Yuan, Ying et al. | 2023
-
Receptor tyrosine kinases: biological functions and anticancer targeted therapyZhang, Nan / Li, Yongsheng et al. | 2023
-
NLRP3/IL‐1β induced myeloid‐derived suppressor cells recruitment and PD‐L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinomaLiu, Wenfeng / Zhang, Feng / Quan, Bing / Yao, Fan / Chen, Rongxin / Ren, Zhenggang / Yin, Xin et al. | 2023
-
A novel Bruton's tyrosine kinase inhibitor JDB175 shows potent efficacy to suppress central nervous system lymphomaXia, Yong / Li, Xue / Jiang, Ning / Wei, Xiawei et al. | 2023
-
FOXC1 restrains NF‐κB‐mediated interleukin‐1β transcription in breast cancerLiu, Yan / Chen, Shuang / Tian, Mao / Giuliano, Armando / Cui, Xiaojiang et al. | 2023
-
Role of the immune system in liver transplantation and its implications for therapeutic interventionsChen, Guanrong / Hu, Xin / Huang, Yingchen / Xiang, Xiaonan / Pan, Sheng / Chen, Ronggao / Xu, Xiao et al. | 2023
-
Long‐term immune response to Omicron‐specific mRNA vaccination in mice, hamsters, and nonhuman primatesWu, Yi / Wu, Namei / Jia, Xiaoying / Wu, Yan / Zhang, Xinghai / Liu, Yang / Hou, Yuxia / Shen, Yanqiong / Li, Entao / Wang, Wei et al. | 2023
-
STAT4 facilitates PD‐L1 level via IL‐12R/JAK2/STAT3 axis and predicts immunotherapy response in breast cancerZhou, Jianbo / Wan, Feng / Wang, Li / Peng, Cheng / Huang, Ruizhen / Peng, Fu et al. | 2023
-
Decellularized diseased tissues: current state‐of‐the‐art and future directionsLi, Xiang / Shan, Jianyang / Chen, Xin / Cui, Haomin / Wen, Gen / Yu, Yaling et al. | 2023
-
Epigenetic regulation in lung cancerRamazi, Shahin / Dadzadi, Maedeh / Sahafnejad, Zahra / Allahverdi, Abdollah et al. | 2023
-
Short‐term fasting attenuates lipopolysaccharide/D‐galactosamine‐induced acute liver failure through Sirt1‐autophagy signaling in miceLong, Boyu / Tao, Hongyun / Tong, Shiwen / Wang, Xuefu / Yin, Wenwei et al. | 2023
-
Glucagon‐like peptide‐1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolismLin, Ke / Dong, Chunyan / Zhao, Binyan / Zhou, Bailing / Yang, Li et al. | 2023
-
The pathogenesis and potential therapeutic targets in sepsisZhang, Wendan / Jiang, Honghong / Wu, Gaosong / Huang, Pengli / Wang, Haonan / An, Huazhang / Liu, Sanhong / Zhang, Weidong et al. | 2023
-
A cell‐penetrating peptide exerts therapeutic effects against ischemic stroke by mediating the lysosomal degradation of sirtuin 5Xia, Qian / Zhang, Xue / Zhan, Gaofeng / Zheng, Lu / Mao, Meng / Zhao, Yin / Zhao, Yilin / Li, Xing et al. | 2023
-
The determinants associated with zoonotic potential of influenza A viruses: BTN3A3 evasion mediated by residue mutation in the nucleoproteinTian, Lili / Li, Maochen / Fan, Huahao et al. | 2023
-
The emerging role of exosomes in communication between the periphery and the central nervous systemHan, Wenxiu / Zhang, Hailiang / Feng, Lei / Dang, Ruili / Wang, Jing / Cui, Changmeng / Jiang, Pei et al. | 2023
-
Microbiota in cancer: molecular mechanisms and therapeutic interventionsChen, Zhou / Guan, Defeng / Wang, Zhengfeng / Li, Xin / Dong, Shi / Huang, Junjun / Zhou, Wence et al. | 2023
-
Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapyWang, Yan / Jin, Shengjie / Zhuang, Qiqi / Liu, Na / Chen, Ruyi / Adam, Sofia Abdulkadir / Jin, Jie / Sun, Jie et al. | 2023
-
Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVIDWu, Junzheng / Yang, Huichuan / Yu, Ding / Yang, Xiaoming et al. | 2023
-
Midnolin‐proteasome pathway for protein degradationJin, Wei‐Lin et al. | 2023
-
Probiotics, prebiotics, and postbiotics in health and diseaseJi, Jing / Jin, Weilin / Liu, Shuang‐Jiang / Jiao, Zuoyi / Li, Xiangkai et al. | 2023
-
Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonismChen, Kang / Tang, Fei / Du, Bin / Yue, Zhe‐Zhou / Jiao, Ling‐Ling / Ding, Xu‐Long / Tuo, Qing‐Zhang / Meng, Jie / He, Si‐Yu / Dai, Lunzhi et al. | 2023
-
Biomarkers and experimental models for cancer immunology investigationXu, Hengyi / Jia, Ziqi / Liu, Fengshuo / Li, Jiayi / Huang, Yansong / Jiang, Yiwen / Pu, Pengming / Shang, Tongxuan / Tang, Pengrui / Zhou, Yongxin et al. | 2023
-
Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseasesLi, Qirong / Feng, Qiang / Zhou, Hengzong / Lin, Chao / Sun, Xiaoming / Ma, Chaoyang / Sun, Liqun / Guo, Gongliang / Wang, Dongxu et al. | 2023
-
ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistanceTang, Jianing / Long, Guo / Xiao, Desheng / Liu, Shuang / Xiao, Liang / Zhou, Ledu / Tao, Yongguang et al. | 2023
-
A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strainsYao, Hebang / Wang, Hongyang / Zhang, Zhaoyong / Lu, Yuchi / Zhang, Zhiying / Zhang, Yu / Xiong, Xinyi / Wang, Yanqun / Wang, Zhizhi / Yang, Haitao et al. | 2023
-
Progress in cancer neuroscienceLan, Yu‐Long / Zou, Shuang / Wang, Wen / Chen, Qi / Zhu, Yongjian et al. | 2023
-
O‐GlcNAcylation: cellular physiology and therapeutic target for human diseasesYe, Lin / Ding, Wei / Xiao, Dandan / Jia, Yi / Zhao, Zhonghao / Ao, Xiang / Wang, Jianxun et al. | 2023
-
Urolithin A protects severe acute pancreatitis‐associated acute cardiac injury by regulating mitochondrial fatty acid oxidative metabolism in cardiomyocytesYang, Yue / Hu, Qian / Kang, Hongxin / Li, Juan / Zhao, Xianlin / Zhu, Lv / Tang, Wenfu / Wan, Meihua et al. | 2023
-
Issue Information| 2023
-
A multicenter single‐arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2‐positive breast cancerShi, Qiyun / Qi, Xiaowei / Tang, Peng / Fan, Linjun / Chen, Li / Wang, Shushu / Liang, Yan / Hu, Ying / Wang, Minghao / Ren, Lin et al. | 2023
-
Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases (2023 Edition)Chen, Wenqiang / Ni, Mei / Huang, He / Cong, Hongliang / Fu, Xianghua / Gao, Wei / Yang, Yuejin / Yu, Mengyue / Song, Xiantao / Liu, Meilin et al. | 2023
-
Long‐term complete remission and peripheral biomarkers in Hodgkin lymphoma patients after decitabine‐plus‐camrelizumab epi‐immunotherapy and treatment cessationWang, Chunmeng / Pan, Yuting / Liu, Yang / Guo, Bing / Shi, Jinhong / Rong, Guanghua / Guo, Zhipeng / Li, Zhifang / Yang, Qingming / Nie, Jing et al. | 2023